A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
Eligible age
18+ yrs
Accepts
All genders
Locations
15 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this clinical study is to learn about the safety and effects of berobenatide (PF-08653944) for the treatment of knee osteoarthritis in adults with overweight or obesity. The study will last 52 weeks and compare the effects of berobenatide compared to placebo on knee pain, physical function, and body weight. Study activities will include blood tests, knee pain assessment, physical function questionnaires and body measurements.
Sponsor: Pfizer
You may qualify if…
- ✓ Adults 18 years of age or older, or the minimum age of consent according to local regulations.
- ✓ Body mass index of at least 27 kg/m² at Screening.
- ✓ Currently meets American College of Rheumatology (ACR) Criteria for knee OA.
- ✓ Pain due to knee OA.
- ✓ Knee radiograph consistent with knee osteoarthritis and Kellgren-Lawrence Grade 2 or 3.
- ✓ Willingness to complete the required analgesic washout.
- ✓ History of at least 1 self-reported unsuccessful dietary effort to lose body weight.
You may not qualify if…
- ✕ Self-reported body weight increase or decrease greater than 5% within 90 days before Screening.
- ✕ History of diabetes or Screening laboratory findings indicative of diabetes.
- ✕ Known clinically significant gastric-emptying abnormality, history of acute or chronic pancreatitis, or active symptomatic gallbladder disease.
- ✕ Personal history or first-degree family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2.
- ✕ Significant active or unstable psychiatric disorder.
- ✕ Condition or knee disorder that could confound assessment of target-knee pain.
- ✕ Prior target-knee replacement, planned target-knee replacement, or planned elective knee surgery during the study.
- ✕ Recent use of weight-loss medication, any glucose-lowering therapy, or other protocol-prohibited treatment.
Where it's recruiting
Tempe
Escondido · Rancho Cucamonga · Tustin
Colorado Springs
Clearwater · Doral · Jacksonville · Lady Lake …
Stockbridge · Woodstock
Chicago
Wichita
Gretna
Farmington Hills · Sterling Heights
Albuquerque
Granite Quarry · Monroe · Salisbury · Wilmington
Norman
Source: ClinicalTrials.gov · NCT07919678 · last updated 2026-11-05